ORAGENICS, INC. Proceeds from Short-term Debt
ORAGENICS, INC. (OGEN) reported Proceeds from Short-term Debt of $0 for the 6-month period ending 2011-06-30, per its 10-Q filed 2011-08-05.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromShortTermDebt · last filed 2011-11-14
- ORAGENICS, INC. proceeds from short-term debt for the quarter ending 2010-09-30 was $165.66K.
| Period end | Proceeds from Short-term Debt 3 month | Proceeds from Short-term Debt 6 month | Proceeds from Short-term Debt 9 month |
|---|---|---|---|
| 2011-06-30 | $0.00 10-Q · filed 2011-08-05 | ||
| 2010-09-30 | $165.66K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14 | $216.30K 10-Q · filed 2011-11-14 | |
| 2010-06-30 | $50.64K 10-Q · filed 2011-08-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |